REGENXBIO Inc. Profile Avatar - Palmy Investing

REGENXBIO Inc.

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact…

Biotechnology
US, Rockville [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

REGENXBIO Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

REGENXBIO Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of REGENXBIO Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of RGNX's Analysis
CIK: 1590877 CUSIP: 75901B107 ISIN: US75901B1070 LEI: - UEI: -
Secondary Listings
RGNX has no secondary listings inside our databases.